PXD054276 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors in vivo |
Description | CTNNB1/ ꞵ-catenin is mutated in 3.3% of solid cancers, with several recurrent gain-of-function mutations occurring early during cancer formation. This includes the shared driver mutation CTNNB1S37F, estimated to occur in >7000 new cancer cases in 2024 in the US. However, to offer attractive immunotherapy targets, neoantigens must be presented at sufficient levels on tumor cells to be recognized by T cells. Here, we identify two neopeptides encoded by CTNNB1S37F presented on the frequent HLA-A*02:01 and HLA-A*24:02 alleles, from cell lines naturally expressing the mutation and HLA-alleles. T-cell receptors (TCRs) specifically recognizing the mutant peptides were isolated from naïve healthy donor T cells. T cells re-directed with the CTNNB1S37F TCRs efficiently killed CTNNB1S37F+ cell lines in vitro, eradicated established tumors in an in vivo melanoma mouse model naturally expressing the mutation and prevented relapses during the >100-day follow-up period. TCR T cells targeting CTNNB1S37F could form basis for promising immunotherapy in solid cancers. |
HostingRepository | PRIDE |
AnnounceDate | 2025-07-16 |
AnnouncementXML | Submission_2025-07-16_05:24:23.264.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | The Trung Tran |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | Q Exactive HF |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-07-26 07:53:50 | ID requested | |
1 | 2025-07-15 04:41:16 | announced | |
⏵ 2 | 2025-07-16 05:24:23 | announced | 2025-07-16: Updated project metadata. |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: β-catenin, In Vivo, T cells, Immunotherapy |
Contact List
Johanna Olweus |
contact affiliation | Head, Dept of Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Ullernchausséen 70, 0379 Oslo, Norway |
contact email | johanna.olweus@medisin.uio.no |
lab head | |
The Trung Tran |
contact affiliation | University of Oslo |
contact email | thetrung1268@gmail.com |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/07/PXD054276 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD054276
- Label: PRIDE project
- Name: TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors in vivo